BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy15895
(124 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|4GQT|A Chain A, N-Terminal Domain Of C. Elegans Hsp90
pdb|4GQT|B Chain B, N-Terminal Domain Of C. Elegans Hsp90
Length = 227
Score = 112 bits (279), Expect = 8e-26, Method: Compositional matrix adjust.
Identities = 56/108 (51%), Positives = 81/108 (75%), Gaps = 5/108 (4%)
Query: 18 ASNDNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFP 77
A ++NAE FQAE L+ ++ + YS+KE+++RELISNASDAL+K+RY L+E P
Sbjct: 3 AMSENAETFAFQAEIAQLMSLIINTFYSNKEIYLRELISNASDALDKIRYQALTE----P 58
Query: 78 TDHDHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
++ D GK L I+I+ +K+ + LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 59 SELDTGKELFIKITPNKEEKTLTIMDTGIGMTKADLVNNLGTIAKSGT 106
>pdb|3PEH|A Chain A, Crystal Structure Of The N-Terminal Domain Of An Hsp90
From Plasmodium Falciparum, Pfl1070c In The Presence Of
A Thienopyrimidine Derivative
pdb|3PEH|B Chain B, Crystal Structure Of The N-Terminal Domain Of An Hsp90
From Plasmodium Falciparum, Pfl1070c In The Presence Of
A Thienopyrimidine Derivative
pdb|3PEJ|A Chain A, Crystal Structure Of The N-Terminal Domain Of An Hsp90
From Plasmodium Falciparum, Pfl1070c In The Presence Of
Macbecin
pdb|3PEJ|B Chain B, Crystal Structure Of The N-Terminal Domain Of An Hsp90
From Plasmodium Falciparum, Pfl1070c In The Presence Of
Macbecin
Length = 281
Score = 109 bits (273), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 56/104 (53%), Positives = 77/104 (74%), Gaps = 3/104 (2%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
++ E H++Q E L+DI+ SLY+ KEVF+RELISNA+DALEK+R+ LS+
Sbjct: 21 ESMESHQYQTEVTRLMDIIVNSLYTQKEVFLRELISNAADALEKIRFLSLSDESVL---G 77
Query: 81 DHGKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
+ KLEIRIS +K+ IL+I D+GIGMTK +L +NLGTIA+SG+
Sbjct: 78 EEKKLEIRISANKEKNILSITDTGIGMTKVDLINNLGTIAKSGT 121
>pdb|1AH8|A Chain A, Structure Of The Orthorhombic Form Of The N-Terminal
Domain Of The Yeast Hsp90 Chaperone
pdb|1AH8|B Chain B, Structure Of The Orthorhombic Form Of The N-Terminal
Domain Of The Yeast Hsp90 Chaperone
pdb|1AH6|A Chain A, Structure Of The Tetragonal Form Of The N-Terminal Domain
Of The Yeast Hsp90 Chaperone
Length = 220
Score = 106 bits (265), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 54/102 (52%), Positives = 75/102 (73%), Gaps = 3/102 (2%)
Query: 23 AEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDH 82
+E EFQAE L+ ++ ++YS+KE+F+RELISNASDAL+K+RY LS+ T+ D
Sbjct: 3 SETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSLSDPKQLETEPD- 61
Query: 83 GKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
L IRI+ + ++L I+DSGIGMTK EL +NLGTIA+SG+
Sbjct: 62 --LFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAKSGT 101
>pdb|2BRE|A Chain A, Structure Of A Hsp90 Inhibitor Bound To The N-Terminus Of
Yeast Hsp90.
pdb|2BRE|B Chain B, Structure Of A Hsp90 Inhibitor Bound To The N-Terminus Of
Yeast Hsp90.
pdb|2VWC|A Chain A, Structure Of The Hsp90 Inhibitor Macbecin Bound To The N-
Terminus Of Yeast Hsp90
Length = 219
Score = 106 bits (265), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 54/102 (52%), Positives = 75/102 (73%), Gaps = 3/102 (2%)
Query: 23 AEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDH 82
+E EFQAE L+ ++ ++YS+KE+F+RELISNASDAL+K+RY LS+ T+ D
Sbjct: 3 SETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSLSDPKQLETEPD- 61
Query: 83 GKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
L IRI+ + ++L I+DSGIGMTK EL +NLGTIA+SG+
Sbjct: 62 --LFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAKSGT 101
>pdb|1US7|A Chain A, Complex Of Hsp90 And P50
pdb|2BRC|A Chain A, Structure Of A Hsp90 Inhibitor Bound To The N-Terminus Of
Yeast Hsp90.
pdb|2IWS|A Chain A, Radicicol Analogues Bound To The Atp Site Of Hsp90
pdb|2IWU|A Chain A, Analogues Of Radicicol Bound To The Atp-Binding Site Of
Hsp90
pdb|2IWX|A Chain A, Analogues Of Radicicol Bound To The Atp-Binding Site Of
Hsp90.
pdb|1AMW|A Chain A, Adp Binding Site In The Hsp90 Molecular Chaperone
pdb|2VW5|A Chain A, Structure Of The Hsp90 Inhibitor 7-O-Carbamoylpremacbecin
Bound To The N- Terminus Of Yeast Hsp90
pdb|2VW5|B Chain B, Structure Of The Hsp90 Inhibitor 7-O-Carbamoylpremacbecin
Bound To The N- Terminus Of Yeast Hsp90
pdb|2VW5|C Chain C, Structure Of The Hsp90 Inhibitor 7-O-Carbamoylpremacbecin
Bound To The N- Terminus Of Yeast Hsp90
pdb|2VW5|D Chain D, Structure Of The Hsp90 Inhibitor 7-O-Carbamoylpremacbecin
Bound To The N- Terminus Of Yeast Hsp90
pdb|2XD6|A Chain A, Hsp90 Complexed With A Resorcylic Acid Macrolactone.
pdb|2XX4|A Chain A, Macrolactone Inhibitor Bound To Hsp90 N-Term
pdb|2XX5|A Chain A, Macrolactone Inhibitor Bound To Hsp90 N-Term
Length = 214
Score = 106 bits (265), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 54/102 (52%), Positives = 75/102 (73%), Gaps = 3/102 (2%)
Query: 23 AEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDH 82
+E EFQAE L+ ++ ++YS+KE+F+RELISNASDAL+K+RY LS+ T+ D
Sbjct: 3 SETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSLSDPKQLETEPD- 61
Query: 83 GKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
L IRI+ + ++L I+DSGIGMTK EL +NLGTIA+SG+
Sbjct: 62 --LFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAKSGT 101
>pdb|2CG9|A Chain A, Crystal Structure Of An Hsp90-Sba1 Closed Chaperone
Complex
pdb|2CG9|B Chain B, Crystal Structure Of An Hsp90-Sba1 Closed Chaperone
Complex
Length = 677
Score = 106 bits (265), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 54/102 (52%), Positives = 75/102 (73%), Gaps = 3/102 (2%)
Query: 23 AEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDH 82
+E EFQAE L+ ++ ++YS+KE+F+RELISNASDAL+K+RY LS+ T+ D
Sbjct: 3 SETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSLSDPKQLETEPD- 61
Query: 83 GKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
L IRI+ + ++L I+DSGIGMTK EL +NLGTIA+SG+
Sbjct: 62 --LFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAKSGT 101
>pdb|1A4H|A Chain A, Structure Of The N-Terminal Domain Of The Yeast Hsp90
Chaperone In Complex With Geldanamycin
Length = 230
Score = 106 bits (265), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 54/102 (52%), Positives = 75/102 (73%), Gaps = 3/102 (2%)
Query: 23 AEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDH 82
+E EFQAE L+ ++ ++YS+KE+F+RELISNASDAL+K+RY LS+ T+ D
Sbjct: 13 SETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSLSDPKQLETEPD- 71
Query: 83 GKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
L IRI+ + ++L I+DSGIGMTK EL +NLGTIA+SG+
Sbjct: 72 --LFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAKSGT 111
>pdb|1ZW9|A Chain A, Yeast Hsp82 In Complex With The Novel Hsp90 Inhibitor
8-(6-Bromo-
Benzo[1,
3]dioxol-5-Ylsulfanyl)-9-(3-Isopropylamino-Propyl)-
Adenine
pdb|1ZWH|A Chain A, Yeast Hsp82 In Complex With The Novel Hsp90 Inhibitor
Radester Amine
pdb|2FXS|A Chain A, Yeast Hsp82 In Complex With The Novel Hsp90 Inhibitor
Radamide
Length = 240
Score = 106 bits (265), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 55/107 (51%), Positives = 77/107 (71%), Gaps = 3/107 (2%)
Query: 18 ASNDNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFP 77
S+ +E EFQAE L+ ++ ++YS+KE+F+RELISNASDAL+K+RY LS+
Sbjct: 18 GSHMASETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSLSDPKQLE 77
Query: 78 TDHDHGKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
T+ D L IRI+ + ++L I+DSGIGMTK EL +NLGTIA+SG+
Sbjct: 78 TEPD---LFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAKSGT 121
>pdb|2XX2|A Chain A, Macrolactone Inhibitor Bound To Hsp90 N-Term
pdb|2XX2|B Chain B, Macrolactone Inhibitor Bound To Hsp90 N-Term
pdb|2XX2|C Chain C, Macrolactone Inhibitor Bound To Hsp90 N-Term
pdb|2XX2|D Chain D, Macrolactone Inhibitor Bound To Hsp90 N-Term
Length = 214
Score = 106 bits (265), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 54/102 (52%), Positives = 75/102 (73%), Gaps = 3/102 (2%)
Query: 23 AEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDH 82
+E EFQAE L+ ++ ++YS+KE+F+RELISNASDAL+K+RY LS+ T+ D
Sbjct: 3 SETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSLSDPKQLETEPD- 61
Query: 83 GKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
L IRI+ + ++L I+DSGIGMTK EL +NLGTIA+SG+
Sbjct: 62 --LFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAKSGT 101
>pdb|2CGF|A Chain A, A Radicicol Analogue Bound To The Atp Binding Site Of The
N- Terminal Domain Of The Yeast Hsp90 Chaperone
Length = 225
Score = 106 bits (265), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 54/102 (52%), Positives = 75/102 (73%), Gaps = 3/102 (2%)
Query: 23 AEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDH 82
+E EFQAE L+ ++ ++YS+KE+F+RELISNASDAL+K+RY LS+ T+ D
Sbjct: 14 SETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSLSDPKQLETEPD- 72
Query: 83 GKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
L IRI+ + ++L I+DSGIGMTK EL +NLGTIA+SG+
Sbjct: 73 --LFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAKSGT 112
>pdb|1AM1|A Chain A, Atp Binding Site In The Hsp90 Molecular Chaperone
Length = 213
Score = 106 bits (265), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 54/102 (52%), Positives = 75/102 (73%), Gaps = 3/102 (2%)
Query: 23 AEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDH 82
+E EFQAE L+ ++ ++YS+KE+F+RELISNASDAL+K+RY LS+ T+ D
Sbjct: 2 SETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSLSDPKQLETEPD- 60
Query: 83 GKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
L IRI+ + ++L I+DSGIGMTK EL +NLGTIA+SG+
Sbjct: 61 --LFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAKSGT 100
>pdb|1BGQ|A Chain A, Radicicol Bound To The Atp Binding Site Of The N-Terminal
Domain Of The Yeast Hsp90 Chaperone
Length = 225
Score = 106 bits (265), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 54/102 (52%), Positives = 75/102 (73%), Gaps = 3/102 (2%)
Query: 23 AEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDH 82
+E EFQAE L+ ++ ++YS+KE+F+RELISNASDAL+K+RY LS+ T+ D
Sbjct: 14 SETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSLSDPKQLETEPD- 72
Query: 83 GKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
L IRI+ + ++L I+DSGIGMTK EL +NLGTIA+SG+
Sbjct: 73 --LFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAKSGT 112
>pdb|3HHU|A Chain A, Human Heat-Shock Protein 90 (Hsp90) In Complex With {4-[3-
(2,4-Dihydroxy-5-Isopropyl-Phenyl)-5-Thioxo-
1,5-Dihydro- [1,2,4]triazol-4-Yl]-Benzyl}-Carbamic Acid
Ethyl Ester {zk 2819}
pdb|3HHU|B Chain B, Human Heat-Shock Protein 90 (Hsp90) In Complex With {4-[3-
(2,4-Dihydroxy-5-Isopropyl-Phenyl)-5-Thioxo-
1,5-Dihydro- [1,2,4]triazol-4-Yl]-Benzyl}-Carbamic Acid
Ethyl Ester {zk 2819}
Length = 224
Score = 105 bits (262), Expect = 6e-24, Method: Compositional matrix adjust.
Identities = 55/113 (48%), Positives = 78/113 (69%), Gaps = 5/113 (4%)
Query: 13 TQAEAASNDNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSE 72
TQ + + E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++
Sbjct: 7 TQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD 66
Query: 73 VMPFPTDHDHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
P+ D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 67 ----PSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 115
>pdb|1UYI|A Chain A, Human Hsp90-Alpha With
8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-
Pent-9h-Purin-6-Ylamine
Length = 236
Score = 105 bits (262), Expect = 7e-24, Method: Compositional matrix adjust.
Identities = 55/113 (48%), Positives = 79/113 (69%), Gaps = 5/113 (4%)
Query: 13 TQAEAASNDNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSE 72
TQ + ++ E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++
Sbjct: 7 TQDQPMEEEHVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD 66
Query: 73 VMPFPTDHDHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
P+ D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 67 ----PSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 115
>pdb|3D0B|A Chain A, Crystal Structure Of Benzamide
Tetrahydro-4h-Carbazol-4-One Bound To Hsp90
pdb|3MNR|P Chain P, Crystal Structure Of Benzamide Snx-1321 Bound To Hsp90
Length = 232
Score = 105 bits (262), Expect = 7e-24, Method: Compositional matrix adjust.
Identities = 55/113 (48%), Positives = 78/113 (69%), Gaps = 5/113 (4%)
Query: 13 TQAEAASNDNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSE 72
TQ + + E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++
Sbjct: 7 TQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD 66
Query: 73 VMPFPTDHDHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
P+ D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 67 ----PSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 115
>pdb|2WEP|A Chain A, Yeast Hsp90 N-Terminal Domain Li-Iv Mutant With Adp
pdb|2WEQ|A Chain A, Yeast Hsp90 N-Terminal Domain Li-Iv Mutant With
Geldanamycin
pdb|2WER|A Chain A, Yeast Hsp90 N-Terminal Domain Li-Iv Mutant With Radicicol
pdb|2WER|B Chain B, Yeast Hsp90 N-Terminal Domain Li-Iv Mutant With Radicicol
Length = 220
Score = 105 bits (261), Expect = 7e-24, Method: Compositional matrix adjust.
Identities = 52/102 (50%), Positives = 75/102 (73%), Gaps = 3/102 (2%)
Query: 23 AEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDH 82
+E EFQAE L+ ++ ++YS+KE+F+RE++SNASDAL+K+RY LS+ T+ D
Sbjct: 3 SETFEFQAEITQLMSLIINTVYSNKEIFLREIVSNASDALDKIRYKSLSDPKQLETEPD- 61
Query: 83 GKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
L IRI+ + ++L I+DSGIGMTK EL +NLGTIA+SG+
Sbjct: 62 --LFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAKSGT 101
>pdb|1UY6|A Chain A, Human Hsp90-Alpha With
9-Butyl-8-(3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine
pdb|1UY7|A Chain A, Human Hsp90-alpha With
9-butyl-8-(4-methoxy-benzyl)-9h-purin-6-ylamine
pdb|1UY8|A Chain A, Human Hsp90-Alpha With
9-Butyl-8-(3-Trimethoxy-Benzyl)-9h-Purin-6ylamine
pdb|1UY9|A Chain A, Human Hsp90-Alpha With
8-Benzo[1,3]dioxol-,
5-Ylmethyl-9-Butyl-9h-Purin-6-Ylamine
pdb|1UYC|A Chain A, Human Hsp90-Alpha With
9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine
pdb|1UYD|A Chain A, Human Hsp90-Alpha With 9-Butyl-8-
(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine
pdb|1UYE|A Chain A, Human Hsp90-Alpha With
8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)
-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
pdb|1UYF|A Chain A, Human Hsp90-Alpha With
8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)
-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
pdb|1UYG|A Chain A, Human Hsp90-Alpha With
8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
pdb|1UYH|A Chain A, Human Hsp90-Alpha With 9-Butyl-8-
(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
pdb|1UYK|A Chain A, Human Hsp90-Alpha With
8-Benzo[1,3]dioxol-,5-Ylmethyl-9-But
Yl-2-Fluoro-9h-Purin-6-Ylamine
pdb|1UYL|A Chain A, Structure-Activity Relationships In Purine-Based Inhibitor
Binding To Hsp90 Isoforms
pdb|2UWD|A Chain A, Inhibition Of The Hsp90 Molecular Chaperone In Vitro And
In Vivo By Novel, Synthetic, Potent Resorcinylic
Pyrazole, Isoxazole Amide Analogs
pdb|2VCI|A Chain A, 4,5 Diaryl Isoxazole Hsp90 Chaperone Inhibitors: Potential
Therapeutic Agents For The Treatment Of Cancer
pdb|2VCJ|A Chain A, 4,5 Diaryl Isoxazole Hsp90 Chaperone Inhibitors: Potential
Therapeutic Agents For The Treatment Of Cancer
pdb|2WI1|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
Hsp90 Chaperone
pdb|2WI2|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
Hsp90 Chaperone
pdb|2WI2|B Chain B, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
Hsp90 Chaperone
pdb|2WI3|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
Hsp90 Chaperone
pdb|2WI4|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
Hsp90 Chaperone
pdb|2WI5|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
Hsp90 Chaperone
pdb|2WI6|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
Hsp90 Chaperone
pdb|2WI7|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The
Hsp90 Chaperone
pdb|4FCP|A Chain A, Targetting Conserved Water Molecules: Design Of
4-Aryl-5-Cyanopyrrolo [2,3-D] Pyrimidine Hsp90
Inhibitors Using Fragment-Based Screening And
Structure-Based Optimization
pdb|4FCP|B Chain B, Targetting Conserved Water Molecules: Design Of
4-Aryl-5-Cyanopyrrolo [2,3-D] Pyrimidine Hsp90
Inhibitors Using Fragment-Based Screening And
Structure-Based Optimization
pdb|4FCQ|A Chain A, Targeting Conserved Water Molecules: Design Of 4-Aryl-5-
Cyanopyrrolo[2,3-D]pyrimidine Hsp90 Inhibitors Using
Fragment-Based Screening And Structure-Based
Optimization
pdb|4FCR|A Chain A, Targeting Conserved Water Molecules: Design Of 4-Aryl-5-
Cyanopyrrolo[2,3-D]pyrimidine Hsp90 Inhibitors Using
Fragment-Based Screening And Structure-Based
Optimization
Length = 236
Score = 105 bits (261), Expect = 8e-24, Method: Compositional matrix adjust.
Identities = 55/113 (48%), Positives = 78/113 (69%), Gaps = 5/113 (4%)
Query: 13 TQAEAASNDNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSE 72
TQ + + E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++
Sbjct: 7 TQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD 66
Query: 73 VMPFPTDHDHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
P+ D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 67 ----PSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 115
>pdb|2YI0|A Chain A, Structural Characterization Of
5-Aryl-4-(5-Substituted-2-4-
Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors.
pdb|2YI5|A Chain A, Structural Characterization Of
5-Aryl-4-(5-Substituted-2-4-
Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors.
pdb|2YI6|A Chain A, Structural Characterization Of 5-Aryl-4-(5-Substituted-2-
4-Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors.
pdb|2YI7|A Chain A, Structural Characterization Of
5-Aryl-4-(5-Substituted-2-4-
Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors
Length = 229
Score = 105 bits (261), Expect = 8e-24, Method: Compositional matrix adjust.
Identities = 55/113 (48%), Positives = 78/113 (69%), Gaps = 5/113 (4%)
Query: 13 TQAEAASNDNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSE 72
TQ + + E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++
Sbjct: 7 TQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD 66
Query: 73 VMPFPTDHDHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
P+ D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 67 ----PSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 115
>pdb|2CCS|A Chain A, Human Hsp90 With
4-Chloro-6-(4-Piperazin-1-Yl-1h-Pyrazol-3-
Yl)-Benzene-1,2-Diol
pdb|2CCT|A Chain A, Human Hsp90 With 5-(5-Chloro-2,4-Dihydroxy-Phenyl)-4-
Piperazin-1-Yl-2h-Pyrazole-3-Carboxylic Acid Ethylamide
pdb|2CCU|A Chain A, Human Hsp90 With 4-Chloro-6-(4-(4-(4-Methanesulphonyl-
Benzyl)-Pierazin-1-Yl)-1h-Pyrazol-3-Yl)-Benzene-1,3-Diol
Length = 236
Score = 105 bits (261), Expect = 8e-24, Method: Compositional matrix adjust.
Identities = 55/113 (48%), Positives = 78/113 (69%), Gaps = 5/113 (4%)
Query: 13 TQAEAASNDNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSE 72
TQ + + E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++
Sbjct: 7 TQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYETLTD 66
Query: 73 VMPFPTDHDHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
P+ D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 67 ----PSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 115
>pdb|3QDD|A Chain A, Hsp90a N-Terminal Domain In Complex With Biib021
Length = 237
Score = 105 bits (261), Expect = 9e-24, Method: Compositional matrix adjust.
Identities = 55/113 (48%), Positives = 78/113 (69%), Gaps = 5/113 (4%)
Query: 13 TQAEAASNDNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSE 72
TQ + + E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++
Sbjct: 8 TQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD 67
Query: 73 VMPFPTDHDHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
P+ D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 68 ----PSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 116
>pdb|2FWY|A Chain A, Structure Of Human Hsp90-Alpha Bound To The Potent Water
Soluble Inhibitor Pu-H64
pdb|2FWZ|A Chain A, Structure Of Human Hsp90-alpha Bound To The Potent Water
Soluble Inhibitor Pu-h71
pdb|2H55|A Chain A, Structure Of Human Hsp90-Alpha Bound To The Potent Water
Soluble Inhibitor Pu-Dz8
pdb|3O0I|A Chain A, Structure Of The Human Hsp90-Alpha N-Domain Bound To The
Hsp90 Inhibitor Pu-H54
Length = 256
Score = 105 bits (261), Expect = 9e-24, Method: Compositional matrix adjust.
Identities = 55/113 (48%), Positives = 78/113 (69%), Gaps = 5/113 (4%)
Query: 13 TQAEAASNDNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSE 72
TQ + + E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++
Sbjct: 27 TQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD 86
Query: 73 VMPFPTDHDHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
P+ D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 87 ----PSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 135
>pdb|2BSM|A Chain A, Novel, Potent Small Molecule Inhibitors Of The Molecular
Chaperone Hsp90 Discovered Through Structure-Based
Design
pdb|2BT0|A Chain A, Novel, Potent Small Molecule Inhibitors Of The Molecular
Chaperone Hsp90 Discovered Through Structure-Based
Design
pdb|2BT0|B Chain B, Novel, Potent Small Molecule Inhibitors Of The Molecular
Chaperone Hsp90 Discovered Through Structure-Based
Design
pdb|2BYH|A Chain A, 3-(5-Chloro-2,4-Dihydroxyphenyl)-Pyrazole-4-Carboxamides
As Inhibitors Of The Hsp90 Molecular Chaperone
pdb|2BYI|A Chain A, 3-(5-Chloro-2,4-Dihydroxyphenyl)-Pyrazole-4-Carboxamides
As Inhibitors Of The Hsp90 Molecular Chaperone
pdb|2BZ5|A Chain A, Structure-Based Discovery Of A New Class Of Hsp90
Inhibitors
pdb|2BZ5|B Chain B, Structure-Based Discovery Of A New Class Of Hsp90
Inhibitors
Length = 235
Score = 105 bits (261), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 55/113 (48%), Positives = 78/113 (69%), Gaps = 5/113 (4%)
Query: 13 TQAEAASNDNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSE 72
TQ + + E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++
Sbjct: 6 TQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD 65
Query: 73 VMPFPTDHDHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
P+ D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 66 ----PSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 114
>pdb|2YGF|A Chain A, L89v, L93i And V136m Mutant Of N-term Hsp90 Complexed With
Geldanamycin
Length = 220
Score = 104 bits (260), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 52/102 (50%), Positives = 75/102 (73%), Gaps = 3/102 (2%)
Query: 23 AEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDH 82
+E EFQAE L+ ++ ++YS+KE+F+RELISNASDAL+K+RY LS+ T+ D
Sbjct: 3 SETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSLSDPKQLETEPD- 61
Query: 83 GKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
L IRI+ + ++L I+DSGIGMTK E+ +N+GTIA+SG+
Sbjct: 62 --LFIRITPKPEQKVLEIRDSGIGMTKAEVINNIGTIAKSGT 101
>pdb|2YGE|A Chain A, E88g-n92l Mutant Of N-term Hsp90 Complexed With
Geldanamycin
Length = 220
Score = 104 bits (259), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 53/102 (51%), Positives = 74/102 (72%), Gaps = 3/102 (2%)
Query: 23 AEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDH 82
+E EFQAE L+ ++ ++YS+KE+F+RELISNASDAL+++RY LS+ T+ D
Sbjct: 3 SETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDRIRYKSLSDPKQLETEPD- 61
Query: 83 GKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
L IRI+ + ++L I+DSGIGMTK EL +NLGTIA SG+
Sbjct: 62 --LFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIANSGT 101
>pdb|3C0E|A Chain A, Yeast Hsp82 N-Terminal Domain: Effects Of Mutants 98-99
Ks- Aa
pdb|3C11|A Chain A, Yeast Hsp82 N-Terminal Domain-Geldanamycin Complex:
Effects Of Mutants 98-99 Ks-Aa
Length = 240
Score = 104 bits (259), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 54/107 (50%), Positives = 76/107 (71%), Gaps = 3/107 (2%)
Query: 18 ASNDNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFP 77
S+ +E EFQAE L+ ++ ++YS+KE+F+RELISNASDAL+K+RY LS+
Sbjct: 18 GSHMASETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSLSDPKQLE 77
Query: 78 TDHDHGKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
T+ D L IRI+ + ++L I+DSGIGMTK EL +NLGTIA +G+
Sbjct: 78 TEPD---LFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAAAGT 121
>pdb|3K97|A Chain A, Hsp90 N-Terminal Domain In Complex With
4-Chloro-6-{[(2r)-2-
(2-Methylphenyl)pyrrolidin-1-Yl]carbonyl}benzene-1,
3-Diol
Length = 251
Score = 103 bits (257), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 54/118 (45%), Positives = 79/118 (66%), Gaps = 5/118 (4%)
Query: 8 NHHYSTQAEAASNDNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRY 67
N ++ + + E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY
Sbjct: 17 NLYFQALDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRY 76
Query: 68 NQLSEVMPFPTDHDHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
L++ P+ D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 77 ESLTD----PSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 130
>pdb|2QFO|A Chain A, Hsp90 Complexed With A143571 And A516383
pdb|2QFO|B Chain B, Hsp90 Complexed With A143571 And A516383
pdb|2QG0|A Chain A, Hsp90 Complexed With A943037
pdb|2QG0|B Chain B, Hsp90 Complexed With A943037
Length = 207
Score = 103 bits (256), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 53/103 (51%), Positives = 74/103 (71%), Gaps = 5/103 (4%)
Query: 23 AEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDH 82
E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+ D
Sbjct: 1 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD----PSKLDS 56
Query: 83 GK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 57 GKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 99
>pdb|2QF6|A Chain A, Hsp90 Complexed With A56322
pdb|2QF6|B Chain B, Hsp90 Complexed With A56322
pdb|2QF6|C Chain C, Hsp90 Complexed With A56322
pdb|2QF6|D Chain D, Hsp90 Complexed With A56322
pdb|2QG2|A Chain A, Hsp90 Complexed With A917985
pdb|3OW6|A Chain A, Crystal Structure Of Hsp90 With N-Aryl-Benzimidazolone I
pdb|3OWB|A Chain A, Crystal Structure Of Hsp90 With Ver-49009
pdb|3OWD|A Chain A, Crystal Structure Of Hsp90 With N-Aryl-Benzimidazolone Ii
Length = 207
Score = 103 bits (256), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 53/103 (51%), Positives = 74/103 (71%), Gaps = 5/103 (4%)
Query: 23 AEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDH 82
E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+ D
Sbjct: 1 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYETLTD----PSKLDS 56
Query: 83 GK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 57 GKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 99
>pdb|1OSF|A Chain A, Human Hsp90 In Complex With 17-desmethoxy-17-n,n-
Dimethylaminoethylamino-geldanamycin
Length = 215
Score = 103 bits (256), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 53/105 (50%), Positives = 75/105 (71%), Gaps = 5/105 (4%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
+ E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+
Sbjct: 7 EEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD----PSKL 62
Query: 81 DHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 63 DSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 107
>pdb|3TUH|A Chain A, Crystal Structure Of The N-Terminal Domain Of An Hsp90 In
The Presence Of An The Inhibitor Ganetespib
pdb|3TUH|B Chain B, Crystal Structure Of The N-Terminal Domain Of An Hsp90 In
The Presence Of An The Inhibitor Ganetespib
Length = 209
Score = 103 bits (256), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 53/103 (51%), Positives = 74/103 (71%), Gaps = 5/103 (4%)
Query: 23 AEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDH 82
E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+ D
Sbjct: 2 VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD----PSKLDS 57
Query: 83 GK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 58 GKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 100
>pdb|2K5B|A Chain A, Human Cdc37-Hsp90 Docking Model Based On Nmr
Length = 210
Score = 103 bits (256), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 53/105 (50%), Positives = 75/105 (71%), Gaps = 5/105 (4%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
+ E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+
Sbjct: 2 EEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYETLTD----PSKL 57
Query: 81 DHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 58 DSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 102
>pdb|2JJC|A Chain A, Hsp90 Alpha Atpase Domain With Bound Small Molecule
Fragment
Length = 218
Score = 103 bits (256), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 53/105 (50%), Positives = 75/105 (71%), Gaps = 5/105 (4%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
+ E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+
Sbjct: 10 EEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD----PSKL 65
Query: 81 DHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 66 DSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 110
>pdb|3K98|A Chain A, Hsp90 N-Terminal Domain In Complex With
(1r)-2-(5-Chloro-2,
4-Dihydroxybenzoyl)-N-Ethylisoindoline-1-Carboxamide
pdb|3K98|B Chain B, Hsp90 N-Terminal Domain In Complex With
(1r)-2-(5-Chloro-2,
4-Dihydroxybenzoyl)-N-Ethylisoindoline-1-Carboxamide
pdb|3K99|A Chain A, Hsp90 N-Terminal Domain In Complex With 4-(1,3-Dihydro-2h-
Isoindol-2-Ylcarbonyl)benzene-1,3-Diol
pdb|3K99|B Chain B, Hsp90 N-Terminal Domain In Complex With 4-(1,3-Dihydro-2h-
Isoindol-2-Ylcarbonyl)benzene-1,3-Diol
pdb|3K99|C Chain C, Hsp90 N-Terminal Domain In Complex With 4-(1,3-Dihydro-2h-
Isoindol-2-Ylcarbonyl)benzene-1,3-Diol
pdb|3K99|D Chain D, Hsp90 N-Terminal Domain In Complex With 4-(1,3-Dihydro-2h-
Isoindol-2-Ylcarbonyl)benzene-1,3-Diol
Length = 232
Score = 103 bits (256), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 53/105 (50%), Positives = 75/105 (71%), Gaps = 5/105 (4%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
+ E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+
Sbjct: 8 EEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD----PSKL 63
Query: 81 DHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 64 DSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 108
>pdb|3EKO|A Chain A, Dihydroxylphenyl Amides As Inhibitors Of The Hsp90
Molecular Chaperone
pdb|3EKO|B Chain B, Dihydroxylphenyl Amides As Inhibitors Of The Hsp90
Molecular Chaperone
pdb|3EKR|A Chain A, Dihydroxylphenyl Amides As Inhibitors Of The Hsp90
Molecular Chaperone
pdb|3EKR|B Chain B, Dihydroxylphenyl Amides As Inhibitors Of The Hsp90
Molecular Chaperone
pdb|3HEK|A Chain A, Hsp90 N-Terminal Domain In Complex With 1-{4-[(2r)-1-(5-
Chloro-2,4-Dihydroxybenzoyl)pyrrolidin-2-Yl]benzyl}-3,3-
Difluoropyrrolidinium
pdb|3HEK|B Chain B, Hsp90 N-Terminal Domain In Complex With 1-{4-[(2r)-1-(5-
Chloro-2,4-Dihydroxybenzoyl)pyrrolidin-2-Yl]benzyl}-3,3-
Difluoropyrrolidinium
pdb|3R4N|A Chain A, Optimization Of Potent, Selective, And Orally Bioavailable
Pyrrolodinopyrimidine-Containing Inhibitors Of Heat
Shock Protein 90. Identification Of Development
Candidate 2-Amino-4-{4-Chloro-2-[2-(4-
Fluoro-1h-Pyrazol-1-Yl)ethoxy]-6-Methylphenyl}-N-(2,2-
Difluoropropyl)-5,7-Dihydro-6h-Pyrrolo[3,
4-D]pyrimidine-6-Carboxamide
pdb|3R4N|B Chain B, Optimization Of Potent, Selective, And Orally Bioavailable
Pyrrolodinopyrimidine-Containing Inhibitors Of Heat
Shock Protein 90. Identification Of Development
Candidate 2-Amino-4-{4-Chloro-2-[2-(4-
Fluoro-1h-Pyrazol-1-Yl)ethoxy]-6-Methylphenyl}-N-(2,2-
Difluoropropyl)-5,7-Dihydro-6h-Pyrrolo[3,
4-D]pyrimidine-6-Carboxamide
pdb|3R4O|A Chain A, Optimization Of Potent, Selective, And Orally Bioavailable
Pyrrolodinopyrimidine-Containing Inhibitors Of Heat
Shock Protein 90. Identification Of Development
Candidate 2-Amino-4-{4-Chloro-2-[2-(4-
Fluoro-1h-Pyrazol-1-Yl)ethoxy]-6-Methylphenyl}-N-(2,2-
Difluoropropyl)-5,7-Dihydro-6h-Pyrrolo[3,
4-D]pyrimidine-6-Carboxamide
pdb|3R4O|B Chain B, Optimization Of Potent, Selective, And Orally Bioavailable
Pyrrolodinopyrimidine-Containing Inhibitors Of Heat
Shock Protein 90. Identification Of Development
Candidate 2-Amino-4-{4-Chloro-2-[2-(4-
Fluoro-1h-Pyrazol-1-Yl)ethoxy]-6-Methylphenyl}-N-(2,2-
Difluoropropyl)-5,7-Dihydro-6h-Pyrrolo[3,
4-D]pyrimidine-6-Carboxamide
pdb|3R4P|A Chain A, Optimization Of Potent, Selective, And Orally Bioavailable
Pyrrolodinopyrimidine-Containing Inhibitors Of Heat
Shock Protein 90. Identification Of Development
Candidate 2-Amino-4-{4-Chloro-2-[2-(4-
Fluoro-1h-Pyrazol-1-Yl)ethoxy]-6-Methylphenyl}-N-(2,2-
Difluoropropyl)-5,7-Dihydro-6h-Pyrrolo[3,
4-D]pyrimidine-6-Carboxamide
pdb|3R4P|B Chain B, Optimization Of Potent, Selective, And Orally Bioavailable
Pyrrolodinopyrimidine-Containing Inhibitors Of Heat
Shock Protein 90. Identification Of Development
Candidate 2-Amino-4-{4-Chloro-2-[2-(4-
Fluoro-1h-Pyrazol-1-Yl)ethoxy]-6-Methylphenyl}-N-(2,2-
Difluoropropyl)-5,7-Dihydro-6h-Pyrrolo[3,
4-D]pyrimidine-6-Carboxamide
pdb|3RLP|A Chain A, Co-Crystal Structure Of The Hsp90 Atp Binding Domain In
Complex With
4-(2,
4-Dichloro-5-Methoxyphenyl)-6-Methylpyrimidin-2-Amine
pdb|3RLP|B Chain B, Co-Crystal Structure Of The Hsp90 Atp Binding Domain In
Complex With
4-(2,
4-Dichloro-5-Methoxyphenyl)-6-Methylpyrimidin-2-Amine
pdb|3RLQ|A Chain A, Co-Crystal Structure Of The Hsp90 Atp Binding Domain In
Complex With
4-(2,4-Dichloro-5-Methoxyphenyl)-2-Methyl-7h-Pyrrolo[2,
3- D]pyrimidine-5- Carbonitrile
pdb|3RLQ|B Chain B, Co-Crystal Structure Of The Hsp90 Atp Binding Domain In
Complex With
4-(2,4-Dichloro-5-Methoxyphenyl)-2-Methyl-7h-Pyrrolo[2,
3- D]pyrimidine-5- Carbonitrile
pdb|3RLR|A Chain A, Co-Crystal Structure Of The Hsp90 Atp Binding Domain In
Complex With
4-(2,4-Dichloro-5-Methoxyphenyl)-2,
6-Dimethyl-7h-Pyrrolo[2,3- D]pyrimidine-5-Carbonitrile
pdb|3RLR|B Chain B, Co-Crystal Structure Of The Hsp90 Atp Binding Domain In
Complex With
4-(2,4-Dichloro-5-Methoxyphenyl)-2,
6-Dimethyl-7h-Pyrrolo[2,3- D]pyrimidine-5-Carbonitrile
Length = 226
Score = 103 bits (256), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 53/105 (50%), Positives = 75/105 (71%), Gaps = 5/105 (4%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
+ E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+
Sbjct: 8 EEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD----PSKL 63
Query: 81 DHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 64 DSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 108
>pdb|2XDU|A Chain A, Structre Of Hsp90 With Small Molecule Inhibitor Bound
Length = 236
Score = 103 bits (256), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 53/105 (50%), Positives = 75/105 (71%), Gaps = 5/105 (4%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
+ E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+
Sbjct: 27 EEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD----PSKL 82
Query: 81 DHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 83 DSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 127
>pdb|2YJW|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
pdb|2YJX|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
pdb|2YK2|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
pdb|2YKB|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
pdb|2YKC|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
pdb|2YKE|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
pdb|2YKI|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
pdb|2YKJ|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
pdb|2YK9|A Chain A, Tricyclic Series Of Hsp90 Inhibitors
Length = 209
Score = 103 bits (256), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 53/102 (51%), Positives = 74/102 (72%), Gaps = 5/102 (4%)
Query: 24 EKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDHG 83
E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+ D G
Sbjct: 4 ETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD----PSKLDSG 59
Query: 84 K-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
K L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 60 KELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 101
>pdb|3H80|A Chain A, Crystal Structure Of The Amino-Terminal Domain Of Hsp90
From Leishmania Major, Lmjf33.0312:m1-K213
pdb|3Q5J|A Chain A, Crystal Structure Of The Amino-Terminal Domain Of Hsp90
From Leishmania Major, Lmjf33.0312:m1-K213 In The
Presence Of 17-Dmap- Geldanamycin
pdb|3Q5K|A Chain A, Crystal Structure Of The Amino-Terminal Domain Of Hsp90
From Leishmania Major, Lmjf33.0312:m1-K213 In The
Presence Of An Inhibitor
pdb|3Q5L|A Chain A, Crystal Structure Of The Amino-Terminal Domain Of Hsp90
From Leishmania Major, Lmjf33.0312:m1-K 213 In The
Presence Of 17-Aep- Geldanamycin
pdb|3Q5L|B Chain B, Crystal Structure Of The Amino-Terminal Domain Of Hsp90
From Leishmania Major, Lmjf33.0312:m1-K 213 In The
Presence Of 17-Aep- Geldanamycin
pdb|3Q5L|C Chain C, Crystal Structure Of The Amino-Terminal Domain Of Hsp90
From Leishmania Major, Lmjf33.0312:m1-K 213 In The
Presence Of 17-Aep- Geldanamycin
pdb|3Q5L|D Chain D, Crystal Structure Of The Amino-Terminal Domain Of Hsp90
From Leishmania Major, Lmjf33.0312:m1-K 213 In The
Presence Of 17-Aep- Geldanamycin
pdb|3U67|A Chain A, Crystal Structure Of The N-Terminal Domain Of Hsp90 From
Leishmania Major(Lmjf33.0312)in Complex With Adp
Length = 231
Score = 102 bits (255), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 50/101 (49%), Positives = 72/101 (71%), Gaps = 3/101 (2%)
Query: 24 EKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDHG 83
E FQAE L+ ++ + YS+KE+F+RELISNASDA +K+RY L++ +
Sbjct: 21 ETFAFQAEINQLMSLIINTFYSNKEIFLRELISNASDACDKIRYQSLTDPSVL---GESP 77
Query: 84 KLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
+L IR+ DK+N+ LT++D+GIGMTK +L +NLGTIARSG+
Sbjct: 78 RLCIRVVPDKENKTLTVEDNGIGMTKADLVNNLGTIARSGT 118
>pdb|3BM9|A Chain A, Discovery Of Benzisoxazoles As Potent Inhibitors Of
Chaperone Hsp90
pdb|3BMY|A Chain A, Discovery Of Benzisoxazoles As Potent Inhibitors Of
Chaperone Hsp90
pdb|3QTF|A Chain A, Design And Sar Of Macrocyclic Hsp90 Inhibitors With
Increased Metabolic Stability And Potent
Cell-Proliferation Activity
pdb|3R91|A Chain A, Macrocyclic Lactams As Potent Hsp90 Inhibitors With
Excellent Tumor Exposure And Extended Biomarker
Activity.
pdb|3R92|A Chain A, Discovery Of A Macrocyclic O-Aminobenzamide Hsp90
Inhibitor With Heterocyclic Tether That Shows Extended
Biomarker Activity And In Vivo Efficacy In A Mouse
Xenograft Model.
pdb|3RKZ|A Chain A, Discovery Of A Stable Macrocyclic O-Aminobenzamide Hsp90
Inhibitor Capable Of Significantly Decreasing Tumor
Volume In A Mouse Xenograft Model
Length = 226
Score = 102 bits (255), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 53/105 (50%), Positives = 75/105 (71%), Gaps = 5/105 (4%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
+ E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+
Sbjct: 5 EEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD----PSKL 60
Query: 81 DHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 61 DSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 105
>pdb|3INW|A Chain A, Hsp90 N-Terminal Domain With Pochoxime A
pdb|3INX|A Chain A, Hsp90 N-Terminal Domain With Pochoxime B
Length = 228
Score = 102 bits (255), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 53/105 (50%), Positives = 75/105 (71%), Gaps = 5/105 (4%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
+ E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+
Sbjct: 7 EEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD----PSKL 62
Query: 81 DHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 63 DSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 107
>pdb|3B24|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An
Aminotriazine Fragment Molecule
pdb|3B24|B Chain B, Hsp90 Alpha N-Terminal Domain In Complex With An
Aminotriazine Fragment Molecule
pdb|3B25|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor
Ch4675194
pdb|3B26|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor
Ro1127850
pdb|3B26|B Chain B, Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor
Ro1127850
pdb|3B27|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor
Ro4919127
pdb|3B28|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor
Ch5015765
pdb|3B28|B Chain B, Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor
Ch5015765
pdb|3VHA|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With A
Macrocyclic Inhibitor
pdb|3VHC|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With A
Macrocyclic Inhibitor
pdb|3VHD|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With A
Macrocyclic Inhibitor, Ch5164840
pdb|3VHD|B Chain B, Hsp90 Alpha N-Terminal Domain In Complex With A
Macrocyclic Inhibitor, Ch5164840
Length = 229
Score = 102 bits (255), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 53/105 (50%), Positives = 75/105 (71%), Gaps = 5/105 (4%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
+ E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+
Sbjct: 8 EEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD----PSKL 63
Query: 81 DHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 64 DSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 108
>pdb|2YE7|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YE8|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YEI|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YEJ|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
Length = 252
Score = 102 bits (255), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 53/105 (50%), Positives = 76/105 (72%), Gaps = 5/105 (4%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
++ E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+
Sbjct: 31 EHVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD----PSKL 86
Query: 81 DHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 87 DSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 131
>pdb|3R4M|A Chain A, Optimization Of Potent, Selective, And Orally Bioavailable
Pyrrolodinopyrimidine-Containing Inhibitors Of Heat
Shock Protein 90. Identification Of Development
Candidate 2-Amino-4-{4-Chloro-2-[2-(4-
Fluoro-1h-Pyrazol-1-Yl)ethoxy]-6-Methylphenyl}-N-(2,2-
Difluoropropyl)-5,7-Dihydro-6h-Pyrrolo[3,
4-D]pyrimidine-6-Carboxamide
pdb|3T0H|A Chain A, Structure Insights Into Mechanisms Of Atp Hydrolysis And
The Activation Of Human Hsp90
pdb|3T0Z|A Chain A, Hsp90 N-Terminal Domain Bound To Atp
pdb|3T10|A Chain A, Hsp90 N-Terminal Domain Bound To Acp
pdb|3T1K|A Chain A, Hsp90 N-Terminal Domain Bound To Anp
pdb|3T1K|B Chain B, Hsp90 N-Terminal Domain Bound To Anp
pdb|3T2S|A Chain A, Hsp90 N-Terminal Domain Bound To Ags
pdb|3T2S|B Chain B, Hsp90 N-Terminal Domain Bound To Ags
Length = 228
Score = 102 bits (255), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 53/105 (50%), Positives = 75/105 (71%), Gaps = 5/105 (4%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
+ E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+
Sbjct: 7 EEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD----PSKL 62
Query: 81 DHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 63 DSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 107
>pdb|2XJJ|A Chain A, Structre Of Hsp90 With Small Molecule Inhibitor Bound
pdb|2XJJ|B Chain B, Structre Of Hsp90 With Small Molecule Inhibitor Bound
Length = 249
Score = 102 bits (255), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 53/105 (50%), Positives = 75/105 (71%), Gaps = 5/105 (4%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
+ E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+
Sbjct: 28 EEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD----PSKL 83
Query: 81 DHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 84 DSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 128
>pdb|4AWO|A Chain A, Complex Of Hsp90 Atpase Domain With Tropane Derived
Inhibitors
pdb|4AWO|B Chain B, Complex Of Hsp90 Atpase Domain With Tropane Derived
Inhibitors
pdb|4AWP|A Chain A, Complex Of Hsp90 Atpase Domain With Tropane Derived
Inhibitors
pdb|4AWP|B Chain B, Complex Of Hsp90 Atpase Domain With Tropane Derived
Inhibitors
pdb|4AWQ|A Chain A, Complex Of Hsp90 Atpase Domain With Tropane Derived
Inhibitors
pdb|4AWQ|B Chain B, Complex Of Hsp90 Atpase Domain With Tropane Derived
Inhibitors
Length = 230
Score = 102 bits (255), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 53/105 (50%), Positives = 75/105 (71%), Gaps = 5/105 (4%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
+ E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+
Sbjct: 9 EEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD----PSKL 64
Query: 81 DHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 65 DSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 109
>pdb|4EEH|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor
3-(4- Hydroxy-Phenyl)-1h-Indazol-6-Ol
pdb|4EFT|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor
3-
Cyclohexyl-2-(6-Hydroxy-1h-Indazol-3-Yl)-Propionitrile
pdb|4EFU|A Chain A, Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor
6-Hydroxy- 3-(3-Methyl-Benzyl)-1h-Indazole-5-Carboxylic
Acid Benzyl-Methyl-Amide
Length = 229
Score = 102 bits (254), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 53/105 (50%), Positives = 75/105 (71%), Gaps = 5/105 (4%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
+ E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+
Sbjct: 8 EEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD----PSKL 63
Query: 81 DHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 64 DSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 108
>pdb|4EGH|A Chain A, Hsp90-Alpha Atpase Domain In Complex With
(4-Hydroxyphenyl)morpholin- 4-Yl Methanone
pdb|4EGI|A Chain A, Hsp90-Alpha Atpase Domain In Complex With
2-Amino-4-Ethylthio-6- Methyl-1,3,5-Triazine
pdb|4EGK|A Chain A, Human Hsp90-Alpha Atpase Domain Bound To Radicicol
Length = 232
Score = 102 bits (254), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 53/105 (50%), Positives = 75/105 (71%), Gaps = 5/105 (4%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
+ E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+
Sbjct: 11 EEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD----PSKL 66
Query: 81 DHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 67 DSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 111
>pdb|1Y4S|A Chain A, Conformation Rearrangement Of Heat Shock Protein 90 Upon
Adp Binding
pdb|1Y4S|B Chain B, Conformation Rearrangement Of Heat Shock Protein 90 Upon
Adp Binding
pdb|1Y4U|A Chain A, Conformation Rearrangement Of Heat Shock Protein 90 Upon
Adp Binding
pdb|1Y4U|B Chain B, Conformation Rearrangement Of Heat Shock Protein 90 Upon
Adp Binding
Length = 559
Score = 102 bits (254), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 52/101 (51%), Positives = 73/101 (72%), Gaps = 3/101 (2%)
Query: 24 EKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDHG 83
E FQ+E + LL ++ SLYS+KE+F+RELISNASDA +KLR+ LS + D G
Sbjct: 5 ETRGFQSEVKQLLHLMIHSLYSNKEIFLRELISNASDAADKLRFRALSNPDLYEGD---G 61
Query: 84 KLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
+L +R+S DK R LTI D+G+GMT++E+ +LGTIA+SG+
Sbjct: 62 ELRVRVSFDKDKRTLTISDNGVGMTRDEVIDHLGTIAKSGT 102
>pdb|2YEE|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
Length = 252
Score = 102 bits (254), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 53/105 (50%), Positives = 76/105 (72%), Gaps = 5/105 (4%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
++ E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+
Sbjct: 31 EHVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD----PSKL 86
Query: 81 DHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 87 DSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 131
>pdb|3FT5|A Chain A, Structure Of Hsp90 Bound With A Novel Fragment
pdb|3FT8|A Chain A, Structure Of Hsp90 Bound With A Noval Fragment.
pdb|3HYY|A Chain A, Crystal Structure Of Hsp90 With Fragment 37-D04
pdb|3HYZ|A Chain A, Crystal Structure Of Hsp90 With Fragment 42-C03
pdb|3HYZ|B Chain B, Crystal Structure Of Hsp90 With Fragment 42-C03
pdb|3HZ1|A Chain A, Crystal Structure Of Hsp90 With Fragments 37-D04 And
42-C03
pdb|3HZ5|A Chain A, Crystal Structure Of Hsp90 With Fragment Z064
pdb|2XAB|A Chain A, Structure Of Hsp90 With An Inhibitor Bound
pdb|2XAB|B Chain B, Structure Of Hsp90 With An Inhibitor Bound
pdb|2XJX|A Chain A, Structre Of Hsp90 With Small Molecule Inhibitor Bound
pdb|2XDK|A Chain A, Structure Of Hsp90 With Small Molecule Inhibitor Bound
pdb|2XDL|A Chain A, Structure Of Hsp90 With Small Molecule Inhibitor Bound
pdb|2XDS|A Chain A, Structre Of Hsp90 With Small Molecule Inhibitor Bound
pdb|2XDX|A Chain A, Structre Of Hsp90 With Small Molecule Inhibitor Bound
pdb|2XHR|A Chain A, Structure Of Hsp90 With Small Molecule Inhibitor Bound
pdb|2XHT|A Chain A, Structure Of Hsp90 With Small Molecule Inhibitor Bound
pdb|2XK2|A Chain A, Structre Of Hsp90 With Small Molecule Inhibitor Bound
Length = 249
Score = 102 bits (254), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 53/105 (50%), Positives = 75/105 (71%), Gaps = 5/105 (4%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
+ E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+
Sbjct: 28 EEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD----PSKL 83
Query: 81 DHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 84 DSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 128
>pdb|1BYQ|A Chain A, Hsp90 N-Terminal Domain Bound To Adp-Mg
pdb|1YER|A Chain A, Human Hsp90 Geldanamycin-Binding Domain, "closed"
Conformation
pdb|1YES|A Chain A, Human Hsp90 Geldanamycin-Binding Domain, "open"
Conformation
pdb|1YET|A Chain A, Geldanamycin Bound To The Hsp90 Geldanamycin-Binding
Domain
Length = 228
Score = 102 bits (254), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 53/105 (50%), Positives = 75/105 (71%), Gaps = 5/105 (4%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
+ E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+
Sbjct: 7 EEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYETLTD----PSKL 62
Query: 81 DHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 63 DSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 107
>pdb|1YC1|A Chain A, Crystal Structures Of Human Hsp90alpha Complexed With
Dihydroxyphenylpyrazoles
pdb|1YC3|A Chain A, Crystal Structure Of Human Hsp90alpha Complexed With
Dihydroxyphenylpyrazoles
pdb|1YC4|A Chain A, Crystal Structure Of Human Hsp90alpha Complexed With
Dihydroxyphenylpyrazoles
Length = 264
Score = 102 bits (254), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 53/105 (50%), Positives = 75/105 (71%), Gaps = 5/105 (4%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
+ E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+
Sbjct: 43 EEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYETLTD----PSKL 98
Query: 81 DHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 99 DSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 143
>pdb|2YE2|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YE3|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YE4|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YE5|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YE6|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YE9|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YEA|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YEB|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YEC|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YED|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YEF|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YEG|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YEG|B Chain B, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
pdb|2YEH|A Chain A, Hsp90 Inhibitors And Drugs From Fragment And Virtual
Screening
Length = 252
Score = 102 bits (254), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 53/105 (50%), Positives = 75/105 (71%), Gaps = 5/105 (4%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
+ E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+
Sbjct: 31 EEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTD----PSKL 86
Query: 81 DHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 87 DSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 131
>pdb|2XJG|A Chain A, Structure Of Hsp90 With Small Molecule Inhibitor Bound
pdb|2XHX|A Chain A, Structure Of Hsp90 With Small Molecule Inhibitor Bound
Length = 249
Score = 102 bits (254), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 53/105 (50%), Positives = 75/105 (71%), Gaps = 5/105 (4%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
+ E FQAE L+ ++ + YS+KE+F+RELISN+SDAL+K+RY L++ P+
Sbjct: 28 EEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYETLTD----PSKL 83
Query: 81 DHGK-LEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
D GK L I + +KQ+R LTI D+GIGMTK +L +NLGTIA+SG+
Sbjct: 84 DSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGT 128
>pdb|3K60|A Chain A, Crystal Structure Of N-Terminal Domain Of Plasmodium
Falciparum Hsp90 (Pf07_0029) Bound To Adp
pdb|3K60|B Chain B, Crystal Structure Of N-Terminal Domain Of Plasmodium
Falciparum Hsp90 (Pf07_0029) Bound To Adp
Length = 223
Score = 102 bits (254), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 51/103 (49%), Positives = 71/103 (68%), Gaps = 3/103 (2%)
Query: 22 NAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHD 81
+ E F A+ R L+ ++ + YS+KE+F+RELISNASDAL+K+RY +++ + +
Sbjct: 2 STETFAFNADIRQLMSLIINTFYSNKEIFLRELISNASDALDKIRYESITDTQKLSAEPE 61
Query: 82 HGKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
IRI DK N LTI+DSGIGMTK +L +NLGTIARSG+
Sbjct: 62 ---FFIRIIPDKTNNTLTIEDSGIGMTKNDLINNLGTIARSGT 101
>pdb|2IOP|A Chain A, Crystal Structure Of Full-Length Htpg, The Escherichia
Coli Hsp90, Bound To Adp
pdb|2IOP|B Chain B, Crystal Structure Of Full-Length Htpg, The Escherichia
Coli Hsp90, Bound To Adp
pdb|2IOP|C Chain C, Crystal Structure Of Full-Length Htpg, The Escherichia
Coli Hsp90, Bound To Adp
pdb|2IOP|D Chain D, Crystal Structure Of Full-Length Htpg, The Escherichia
Coli Hsp90, Bound To Adp
pdb|2IOQ|A Chain A, Crystal Structure Of Full-Length Htpg, The Escherichia
Coli Hsp90
pdb|2IOQ|B Chain B, Crystal Structure Of Full-Length Htpg, The Escherichia
Coli Hsp90
Length = 624
Score = 102 bits (254), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 52/101 (51%), Positives = 73/101 (72%), Gaps = 3/101 (2%)
Query: 24 EKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDHG 83
E FQ+E + LL ++ SLYS+KE+F+RELISNASDA +KLR+ LS + D G
Sbjct: 5 ETRGFQSEVKQLLHLMIHSLYSNKEIFLRELISNASDAADKLRFRALSNPDLYEGD---G 61
Query: 84 KLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
+L +R+S DK R LTI D+G+GMT++E+ +LGTIA+SG+
Sbjct: 62 ELRVRVSFDKDKRTLTISDNGVGMTRDEVIDHLGTIAKSGT 102
>pdb|2IOR|A Chain A, Crystal Structure Of The N-Terminal Domain Of Htpg, The
Escherichia Coli Hsp90, Bound To Adp
Length = 235
Score = 102 bits (253), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 52/101 (51%), Positives = 73/101 (72%), Gaps = 3/101 (2%)
Query: 24 EKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDHG 83
E FQ+E + LL ++ SLYS+KE+F+RELISNASDA +KLR+ LS + D G
Sbjct: 25 ETRGFQSEVKQLLHLMIHSLYSNKEIFLRELISNASDAADKLRFRALSNPDLYEGD---G 81
Query: 84 KLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
+L +R+S DK R LTI D+G+GMT++E+ +LGTIA+SG+
Sbjct: 82 ELRVRVSFDKDKRTLTISDNGVGMTRDEVIDHLGTIAKSGT 122
>pdb|3O6O|A Chain A, Crystal Structure Of The N-Terminal Domain Of An Hsp90
From Trypanosoma Brucei, Tb10.26.1080 In The Presence Of
An The Inhibitor Biib021
pdb|3O6O|B Chain B, Crystal Structure Of The N-Terminal Domain Of An Hsp90
From Trypanosoma Brucei, Tb10.26.1080 In The Presence Of
An The Inhibitor Biib021
Length = 214
Score = 101 bits (251), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 51/102 (50%), Positives = 70/102 (68%), Gaps = 3/102 (2%)
Query: 23 AEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDH 82
E FQAE L+ ++ + YS+KE+F+RELISN+SDA +K+RY L+ D H
Sbjct: 3 TETFAFQAEINQLMSLIINTFYSNKEIFLRELISNSSDACDKIRYQSLTN-QSVLGDEPH 61
Query: 83 GKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
L IR+ D+ N+ LT++DSGIGMTK +L +NLGTIARSG+
Sbjct: 62 --LRIRVIPDRVNKTLTVEDSGIGMTKADLVNNLGTIARSGT 101
>pdb|3OPD|A Chain A, Crystal Structure Of The N-Terminal Domain Of An Hsp90
From Trypanosoma Brucei, Tb10.26.1080 In The Presence Of
A Benzamide Derivative
pdb|3OPD|B Chain B, Crystal Structure Of The N-Terminal Domain Of An Hsp90
From Trypanosoma Brucei, Tb10.26.1080 In The Presence Of
A Benzamide Derivative
pdb|3OPD|C Chain C, Crystal Structure Of The N-Terminal Domain Of An Hsp90
From Trypanosoma Brucei, Tb10.26.1080 In The Presence Of
A Benzamide Derivative
pdb|3OMU|A Chain A, Crystal Structure Of The N-Terminal Domain Of An Hsp90
From Trypanosoma Brucei, Tb10.26.1080 In The Presence Of
A Thienopyrimidine Derivative
pdb|3OMU|B Chain B, Crystal Structure Of The N-Terminal Domain Of An Hsp90
From Trypanosoma Brucei, Tb10.26.1080 In The Presence Of
A Thienopyrimidine Derivative
Length = 231
Score = 100 bits (250), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 51/102 (50%), Positives = 70/102 (68%), Gaps = 3/102 (2%)
Query: 23 AEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDH 82
E FQAE L+ ++ + YS+KE+F+RELISN+SDA +K+RY L+ D H
Sbjct: 20 TETFAFQAEINQLMSLIINTFYSNKEIFLRELISNSSDACDKIRYQSLTN-QSVLGDEPH 78
Query: 83 GKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
L IR+ D+ N+ LT++DSGIGMTK +L +NLGTIARSG+
Sbjct: 79 --LRIRVIPDRVNKTLTVEDSGIGMTKADLVNNLGTIARSGT 118
>pdb|3NMQ|A Chain A, Hsp90b N-Terminal Domain In Complex With Ec44, A
Pyrrolo-Pyrimidine Methoxypyridine Inhibitor
Length = 239
Score = 100 bits (250), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 52/98 (53%), Positives = 72/98 (73%), Gaps = 5/98 (5%)
Query: 28 FQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDHGK-LE 86
FQAE L+ ++ + YS+KE+F+RELISNASDAL+K+RY L++ P+ D GK L+
Sbjct: 21 FQAEIAQLMSLIINTFYSNKEIFLRELISNASDALDKIRYESLTD----PSKLDSGKELK 76
Query: 87 IRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
I I + Q R LT+ D+GIGMTK +L +NLGTIA+SG+
Sbjct: 77 IDIIPNPQERTLTLVDTGIGMTKADLINNLGTIAKSGT 114
>pdb|1UYM|A Chain A, Human Hsp90-Beta With Pu3
(9-Butyl-8(3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine)
Length = 220
Score = 100 bits (250), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 52/98 (53%), Positives = 72/98 (73%), Gaps = 5/98 (5%)
Query: 28 FQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDHGK-LE 86
FQAE L+ ++ + YS+KE+F+RELISNASDAL+K+RY L++ P+ D GK L+
Sbjct: 16 FQAEIAQLMSLIINTFYSNKEIFLRELISNASDALDKIRYESLTD----PSKLDSGKELK 71
Query: 87 IRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
I I + Q R LT+ D+GIGMTK +L +NLGTIA+SG+
Sbjct: 72 IDIIPNPQERTLTLVDTGIGMTKADLINNLGTIAKSGT 109
>pdb|2YGA|A Chain A, E88g-n92l Mutant Of N-term Hsp90 Complexed With
Geldanamycin
Length = 220
Score = 100 bits (249), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 52/102 (50%), Positives = 73/102 (71%), Gaps = 3/102 (2%)
Query: 23 AEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDH 82
+E EFQAE L+ ++ ++YS+KE+F+RELISNASDAL+K+RY LS+ T+ D
Sbjct: 3 SETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSLSDPKQLETEPD- 61
Query: 83 GKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
L IRI+ + ++L I+DSGIGMTK L + LGTIA+SG+
Sbjct: 62 --LFIRITPKPEQKVLEIRDSGIGMTKAGLINLLGTIAKSGT 101
>pdb|1U2O|A Chain A, Crystal Structure Of The N-Domain Of Grp94 Lacking The
Charged Domain In Complex With Neca
pdb|1U2O|B Chain B, Crystal Structure Of The N-Domain Of Grp94 Lacking The
Charged Domain In Complex With Neca
pdb|1TBW|A Chain A, Ligand Induced Conformational Shift In The N-Terminal
Domain Of Grp94, Open Conformation
pdb|1TBW|B Chain B, Ligand Induced Conformational Shift In The N-Terminal
Domain Of Grp94, Open Conformation
pdb|1TC0|A Chain A, Ligand Induced Conformational Shifts In The N-Terminal
Domain Of Grp94, Open Conformation Complexed With The
Physiological Partner Atp
pdb|1TC0|B Chain B, Ligand Induced Conformational Shifts In The N-Terminal
Domain Of Grp94, Open Conformation Complexed With The
Physiological Partner Atp
pdb|1TC6|A Chain A, Ligand Induced Conformational Shift In The N-Terminal
Domain Of Grp94, Open Conformation Adp-Complex
pdb|1TC6|B Chain B, Ligand Induced Conformational Shift In The N-Terminal
Domain Of Grp94, Open Conformation Adp-Complex
pdb|1U0Z|A Chain A, N-Domain Of Grp94 Lacking The Charged Domain In Complex
With Radicicol
pdb|1U0Z|B Chain B, N-Domain Of Grp94 Lacking The Charged Domain In Complex
With Radicicol
pdb|1YSZ|A Chain A, Crystal Structure Of The Unliganded Form Of Grp94, The Er
Hsp90: Basis For Nucleotide-Induced Conformational
Change, Grp94n(Delta)41 Apo Crystal Soaked With Neca
pdb|1YT0|A Chain A, Crystal Structure Of The Unliganded Form Of Grp94, The Er
Hsp90: Basis For Nucleotide-Induced Conformational
Change, Grp94n(Delta)41 Apo Crystal Soaked With Adp
pdb|1YT1|A Chain A, Crystal Structure Of The Unliganded Form Of Grp94, The Er
Hsp90: Basis For Nucleotide-Induced Conformational
Change, Grp94n(Delta)41 Apo Crystal
pdb|1YT1|B Chain B, Crystal Structure Of The Unliganded Form Of Grp94, The Er
Hsp90: Basis For Nucleotide-Induced Conformational
Change, Grp94n(Delta)41 Apo Crystal
pdb|2EXL|A Chain A, Grp94 N-Terminal Domain Bound To Geldanamycin
pdb|2EXL|B Chain B, Grp94 N-Terminal Domain Bound To Geldanamycin
pdb|2FYP|A Chain A, Grp94 In Complex With The Novel Hsp90 Inhibitor Radester
Amine
pdb|2FYP|B Chain B, Grp94 In Complex With The Novel Hsp90 Inhibitor Radester
Amine
pdb|2GFD|A Chain A, Grp94 In Complex With The Novel Hsp90 Inhibitor Radamide
pdb|2GFD|B Chain B, Grp94 In Complex With The Novel Hsp90 Inhibitor Radamide
pdb|2GQP|A Chain A, N-Domain Of Grp94 In Complex With The Novel Ligand
N-Propyl Carboxyamido Adenosine
pdb|2GQP|B Chain B, N-Domain Of Grp94 In Complex With The Novel Ligand
N-Propyl Carboxyamido Adenosine
pdb|2HCH|A Chain A, N-Domain Of Grp94 In Complex With The Novel Ligand N-(2-
Amino)ethyl Carboxyamido Adenosine
pdb|2HCH|B Chain B, N-Domain Of Grp94 In Complex With The Novel Ligand N-(2-
Amino)ethyl Carboxyamido Adenosine
pdb|2H8M|A Chain A, N-Domain Of Grp94 In Complex With The 2-Iodo-Neca
pdb|2H8M|B Chain B, N-Domain Of Grp94 In Complex With The 2-Iodo-Neca
pdb|2HG1|A Chain A, N-Domain Of Grp94 In Complex With The Novel Ligand N-(2-
Hydroxyl)ethyl Carboxyamido Adenosine
pdb|2HG1|B Chain B, N-Domain Of Grp94 In Complex With The Novel Ligand N-(2-
Hydroxyl)ethyl Carboxyamido Adenosine
pdb|3O2F|A Chain A, Structure Of The N-Domain Of Grp94 Bound To The Hsp90
Inhibitor Pu-H54
pdb|3O2F|B Chain B, Structure Of The N-Domain Of Grp94 Bound To The Hsp90
Inhibitor Pu-H54
Length = 236
Score = 97.8 bits (242), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 47/104 (45%), Positives = 72/104 (69%), Gaps = 3/104 (2%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
+ +EK FQAE ++ ++ SLY +KE+F+RELISNASDAL+K+R L++ +
Sbjct: 7 EKSEKFAFQAEVNRMMKLIINSLYKNKEIFLRELISNASDALDKIRLISLTDENALAGNE 66
Query: 81 DHGKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
+ L ++I DK+ +L + D+G+GMT+EEL NLGTIA+SG+
Sbjct: 67 E---LTVKIKCDKEKNLLHVTDTGVGMTREELVKNLGTIAKSGT 107
>pdb|1U0Y|A Chain A, N-Domain Of Grp94, With The Charged Domain, In Complex
With The Novel Ligand N-Propyl Carboxyamido Adenosine
pdb|1YT2|A Chain A, Crystal Structure Of The Unliganded Form Of Grp94, The Er
Hsp90: Basis For Nucleotide-Induced Conformational
Change, Grp94n Apo Crystal
Length = 273
Score = 97.8 bits (242), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 47/104 (45%), Positives = 72/104 (69%), Gaps = 3/104 (2%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
+ +EK FQAE ++ ++ SLY +KE+F+RELISNASDAL+K+R L++ +
Sbjct: 7 EKSEKFAFQAEVNRMMKLIINSLYKNKEIFLRELISNASDALDKIRLISLTDENALAGNE 66
Query: 81 DHGKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
+ L ++I DK+ +L + D+G+GMT+EEL NLGTIA+SG+
Sbjct: 67 E---LTVKIKCDKEKNLLHVTDTGVGMTREELVKNLGTIAKSGT 107
>pdb|1QY5|A Chain A, Crystal Structure Of The N-Domain Of The Er Hsp90
Chaperone Grp94 In Complex With The Specific Ligand Neca
pdb|1QY8|A Chain A, Crystal Structure Of The N-domain Of The Er Hsp90
Chaperone Grp94 In Complex With Radicicol
pdb|1QYE|A Chain A, Crystal Structure Of The N-domain Of The Er Hsp90
Chaperone Grp94 In Complex With 2-chlorodideoxyadenosine
Length = 269
Score = 97.8 bits (242), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 47/102 (46%), Positives = 71/102 (69%), Gaps = 3/102 (2%)
Query: 23 AEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDH 82
+EK FQAE ++ ++ SLY +KE+F+RELISNASDAL+K+R L++ + +
Sbjct: 5 SEKFAFQAEVNRMMKLIINSLYKNKEIFLRELISNASDALDKIRLISLTDENALAGNEE- 63
Query: 83 GKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
L ++I DK+ +L + D+G+GMT+EEL NLGTIA+SG+
Sbjct: 64 --LTVKIKCDKEKNLLHVTDTGVGMTREELVKNLGTIAKSGT 103
>pdb|2O1W|A Chain A, Structure Of N-Terminal Plus Middle Domains (N+m) Of Grp94
pdb|2O1W|B Chain B, Structure Of N-Terminal Plus Middle Domains (N+m) Of Grp94
pdb|2O1W|C Chain C, Structure Of N-Terminal Plus Middle Domains (N+m) Of Grp94
pdb|2O1W|D Chain D, Structure Of N-Terminal Plus Middle Domains (N+m) Of Grp94
pdb|2O1W|E Chain E, Structure Of N-Terminal Plus Middle Domains (N+m) Of Grp94
Length = 506
Score = 96.3 bits (238), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 47/102 (46%), Positives = 71/102 (69%), Gaps = 3/102 (2%)
Query: 23 AEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDH 82
+EK FQAE ++ ++ SLY +KE+F+RELISNASDAL+K+R L++ + +
Sbjct: 22 SEKFAFQAEVNRMMKLIINSLYKNKEIFLRELISNASDALDKIRLISLTDENALAGNEE- 80
Query: 83 GKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
L ++I DK+ +L + D+G+GMT+EEL NLGTIA+SG+
Sbjct: 81 --LTVKIKCDKEKNLLHVTDTGVGMTREELVKNLGTIAKSGT 120
>pdb|2XCM|A Chain A, Complex Of Hsp90 N-Terminal, Sgt1 Cs And Rar1 Chord2
Domain
pdb|2XCM|B Chain B, Complex Of Hsp90 N-Terminal, Sgt1 Cs And Rar1 Chord2
Domain
Length = 214
Score = 96.3 bits (238), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 52/107 (48%), Positives = 69/107 (64%), Gaps = 3/107 (2%)
Query: 18 ASNDNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFP 77
A+ E FQAE LL ++ + YS+KE+F+RELISN+SDAL+K+R+ L++
Sbjct: 3 AAATETETFAFQAEINQLLSLIINTFYSNKEIFLRELISNSSDALDKIRFESLTDKSKLD 62
Query: 78 TDHDHGKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
+L I I DK LTI DSGIGMTK +L +NLGTIARSG+
Sbjct: 63 A---QPELFIHIIPDKATSTLTIVDSGIGMTKSDLVNNLGTIARSGT 106
>pdb|2O1U|A Chain A, Structure Of Full Length Grp94 With Amp-Pnp Bound
pdb|2O1U|B Chain B, Structure Of Full Length Grp94 With Amp-Pnp Bound
pdb|2O1V|A Chain A, Structure Of Full Length Grp94 With Adp Bound
pdb|2O1V|B Chain B, Structure Of Full Length Grp94 With Adp Bound
Length = 666
Score = 96.3 bits (238), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 47/102 (46%), Positives = 71/102 (69%), Gaps = 3/102 (2%)
Query: 23 AEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDH 82
+EK FQAE ++ ++ SLY +KE+F+RELISNASDAL+K+R L++ + +
Sbjct: 22 SEKFAFQAEVNRMMKLIINSLYKNKEIFLRELISNASDALDKIRLISLTDENALAGNEE- 80
Query: 83 GKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
L ++I DK+ +L + D+G+GMT+EEL NLGTIA+SG+
Sbjct: 81 --LTVKIKCDKEKNLLHVTDTGVGMTREELVKNLGTIAKSGT 120
>pdb|2ESA|A Chain A, Grp94 N-Terminal Domain Bound To Geldanamycin: Effects Of
Mutants 168- 169 Ks-Aa
Length = 236
Score = 95.5 bits (236), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 46/104 (44%), Positives = 71/104 (68%), Gaps = 3/104 (2%)
Query: 21 DNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDH 80
+ +EK FQAE ++ ++ SLY +KE+F+RELISNASDAL+K+R L++ +
Sbjct: 7 EKSEKFAFQAEVNRMMKLIINSLYKNKEIFLRELISNASDALDKIRLISLTDENALAGNE 66
Query: 81 DHGKLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
+ L ++I DK+ +L + D+G+GMT+EEL NLGTIA +G+
Sbjct: 67 E---LTVKIKCDKEKNLLHVTDTGVGMTREELVKNLGTIAAAGT 107
>pdb|2JKI|A Chain A, Complex Of Hsp90 N-terminal And Sgt1 Cs Domain
pdb|2JKI|B Chain B, Complex Of Hsp90 N-terminal And Sgt1 Cs Domain
pdb|2JKI|C Chain C, Complex Of Hsp90 N-terminal And Sgt1 Cs Domain
Length = 223
Score = 95.1 bits (235), Expect = 8e-21, Method: Compositional matrix adjust.
Identities = 51/101 (50%), Positives = 67/101 (66%), Gaps = 3/101 (2%)
Query: 24 EKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDHG 83
E FQAE LL ++ + YS+KE+F+RELISN+SDAL+K+R+ L++
Sbjct: 12 ETFAFQAEINQLLSLIINTFYSNKEIFLRELISNSSDALDKIRFESLTDKSKLDA---QP 68
Query: 84 KLEIRISTDKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
+L I I DK LTI DSGIGMTK +L +NLGTIARSG+
Sbjct: 69 ELFIHIIPDKATSTLTIVDSGIGMTKSDLVNNLGTIARSGT 109
>pdb|2AKP|A Chain A, Hsp90 Delta24-n210 Mutant
pdb|2AKP|B Chain B, Hsp90 Delta24-n210 Mutant
Length = 186
Score = 88.6 bits (218), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 46/80 (57%), Positives = 61/80 (76%), Gaps = 3/80 (3%)
Query: 45 SDKEVFIRELISNASDALEKLRYNQLSEVMPFPTDHDHGKLEIRISTDKQNRILTIQDSG 104
S+KE+F+RELISNASDAL+K+RY LS+ T+ D L IRI+ + ++L I+DSG
Sbjct: 1 SNKEIFLRELISNASDALDKIRYKSLSDPKQLETEPD---LFIRITPKPEQKVLEIRDSG 57
Query: 105 IGMTKEELKSNLGTIARSGS 124
IGMTK EL +NLGTIA+SG+
Sbjct: 58 IGMTKAELINNLGTIAKSGT 77
>pdb|3IED|A Chain A, Crystal Structure Of N-Terminal Domain Of Plasmodium
Falciparum Hsp90 (Pf14_0417) In Complex With Amppn
Length = 272
Score = 80.5 bits (197), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 57/135 (42%), Positives = 77/135 (57%), Gaps = 33/135 (24%)
Query: 23 AEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRY----NQL-------- 70
EK+ F+AE ++DI+ SLY+DK+VF+RELISNASDA +K R N+L
Sbjct: 24 VEKYNFKAEVNKVMDIIVNSLYTDKDVFLRELISNASDACDKKRIILENNKLIKDAEVVT 83
Query: 71 ------------SEVMPFPTD---------HDHGKLEIRISTDKQNRILTIQDSGIGMTK 109
+E + TD +D KL I+I DK+ + LTI D+GIGM K
Sbjct: 84 NEEIKNETEKEKTENVNESTDKKENVEEEKNDIKKLIIKIKPDKEKKTLTITDNGIGMDK 143
Query: 110 EELKSNLGTIARSGS 124
EL +NLGTIA+SG+
Sbjct: 144 SELINNLGTIAQSGT 158
>pdb|3D36|A Chain A, How To Switch Off A Histidine Kinase: Crystal Structure Of
Geobacillus Stearothermophilus Kinb With The Inhibitor
Sda
pdb|3D36|B Chain B, How To Switch Off A Histidine Kinase: Crystal Structure Of
Geobacillus Stearothermophilus Kinb With The Inhibitor
Sda
Length = 244
Score = 35.4 bits (80), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 31/111 (27%), Positives = 55/111 (49%), Gaps = 15/111 (13%)
Query: 11 YSTQAEAASNDNAEKHEFQAETRMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQL 70
Y T A+ A + EK + E ++DI+ + L + V I+ ++ S E+ ++ Q
Sbjct: 70 YLTFAKPAP-ETPEKLNVKLEIERVIDIL-RPLANMSCVDIQATLAPFSVIGEREKFRQC 127
Query: 71 --------SEVMPFPTDHDHGKLEIRISTDKQNRILTIQDSGIGMTKEELK 113
E MP + G L++ +S D ++ I D+G+GMTKE+L+
Sbjct: 128 LLNVMKNAIEAMP-----NGGTLQVYVSIDNGRVLIRIADTGVGMTKEQLE 173
>pdb|3L8U|A Chain A, Crystal Structure Of Smu.1707c, A Putative Rrna
Methyltransferase From Streptococcus Mutans Ua159
pdb|3L8U|B Chain B, Crystal Structure Of Smu.1707c, A Putative Rrna
Methyltransferase From Streptococcus Mutans Ua159
Length = 182
Score = 25.8 bits (55), Expect = 7.0, Method: Compositional matrix adjust.
Identities = 9/33 (27%), Positives = 23/33 (69%)
Query: 92 DKQNRILTIQDSGIGMTKEELKSNLGTIARSGS 124
+K+N++LT+ + + + + ++ +N G IAR+ +
Sbjct: 7 EKENKLLTLGRNHVVLFQPQIPANTGNIARTCA 39
>pdb|3NZS|A Chain A, Structure-Based Optimization Of Pyrazolo -Pyrimidine And
-Pyridine Inhibitors Of Pi3-Kinase
pdb|3NZU|A Chain A, Structure-Based Optimization Of Pyrazolo -Pyrimidine And
-Pyridine Inhibitors Of Pi3-Kinase
Length = 954
Score = 25.4 bits (54), Expect = 7.5, Method: Composition-based stats.
Identities = 17/47 (36%), Positives = 25/47 (53%), Gaps = 2/47 (4%)
Query: 33 RMLLDIVAKSLYSDKEVFIRELISNASDALEKLRYNQLSEVMPFPTD 79
++ LDI KSL ++K ++IS LE L+ +QL E P D
Sbjct: 598 KVTLDI--KSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYD 642
>pdb|2OCP|A Chain A, Crystal Structure Of Human Deoxyguanosine Kinase
pdb|2OCP|B Chain B, Crystal Structure Of Human Deoxyguanosine Kinase
pdb|2OCP|C Chain C, Crystal Structure Of Human Deoxyguanosine Kinase
pdb|2OCP|D Chain D, Crystal Structure Of Human Deoxyguanosine Kinase
pdb|2OCP|E Chain E, Crystal Structure Of Human Deoxyguanosine Kinase
pdb|2OCP|F Chain F, Crystal Structure Of Human Deoxyguanosine Kinase
pdb|2OCP|G Chain G, Crystal Structure Of Human Deoxyguanosine Kinase
pdb|2OCP|H Chain H, Crystal Structure Of Human Deoxyguanosine Kinase
Length = 241
Score = 25.4 bits (54), Expect = 7.6, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 17/29 (58%)
Query: 31 ETRMLLDIVAKSLYSDKEVFIRELISNAS 59
+ R + I +S+YSD+ +F + L N S
Sbjct: 96 QARKPVQIFERSVYSDRYIFAKNLFENGS 124
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.312 0.128 0.344
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 3,312,636
Number of Sequences: 62578
Number of extensions: 108356
Number of successful extensions: 368
Number of sequences better than 100.0: 93
Number of HSP's better than 100.0 without gapping: 78
Number of HSP's successfully gapped in prelim test: 15
Number of HSP's that attempted gapping in prelim test: 219
Number of HSP's gapped (non-prelim): 93
length of query: 124
length of database: 14,973,337
effective HSP length: 85
effective length of query: 39
effective length of database: 9,654,207
effective search space: 376514073
effective search space used: 376514073
T: 11
A: 40
X1: 16 ( 7.2 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 42 (21.9 bits)
S2: 45 (21.9 bits)